Author: OurCrowd

[Foretellix in PR Newswire] Foretellix and Voxel51 partner to bring scalable 3D neural reconstruction to AI-powered AV development

Dec 9, 2025 |

TEL AVIV, Israel and ANN ARBOR, Mich., Dec. 9, 2025 /PRNewswire/ — Foretellix, the leading Physical AI toolchain provider for safe autonomous vehicles, and Voxel51, the most powerful visual AI data platform, today announced a joint solution that transforms real-world drive logs into high-fidelity 3D scenes and neural reconstructions for training, testing, and validating autonomous vehicle (AV) systems. Read...

Read More

[DeepKeep in PR Newswire] DeepKeep enhances enterprise AI protection with high-precision personal data guardrail

Dec 9, 2025 |

TEL AVIV, Israel, Dec. 9, 2025 /PRNewswire/ — DeepKeep, the platform ensuring secure and trustworthy enterprise AI, today unveiled its Personally Identifiable Information (PII) guardrail, an advanced privacy protection capability designed to detect, redact, and block personal data within AI prompts and responses, preventing unintended data leakage. The guardrail is part of DeepKeep’s suite of over 60 built-in AI guardrails – collectively forming the company’s AI Firewall – within its end-to-end AI security platform.  Read...

Read More

[Alpha Tau in Alpha Tau] Alpha Tau successfully treats first patient in its U.S. trial for patients with recurrent glioblastoma at the James Cancer Hospital at The Ohio State University

Dec 9, 2025 |

Jerusalem, December 9, 2025 – Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) (“Alpha Tau”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT® today announced that the first patient has been treated in its pilot study for the treatment of patients with recurrent glioblastoma multiforme (GBM) using the Alpha DaRT technology. Read...

Read More